Addex Extends Parkinson's Disease Collaboration with Merck & Co., Inc.

Addex Extends Parkinson's Disease Collaboration with Merck & Co., Inc.
PR-CANADA.net - 49 minutes ago
Geneva, Switzerland, - Allosteric modulation company Addex Pharmaceuticals (SIX:ADXN) announced today the extension of its research collaboration with Merck & Co., Inc., through an affiliate, for ...